Antidiabetics Market Emerging Trends in Insulin and Non-Insulin Therapies by 2031
The global antidiabetics market is supported by the continued use of oral medications such as metformin, sulfonylureas, and DPP-4 inhibitors. These drug classes provide treatment options with different mechanisms, costs, and safety profiles, allowing clinicians to select therapies based on patient needs and treatment goals. The antidiabetics market is projected to reach US$ 187.69 billion by...
0 Reacties 0 aandelen 118 Views 0 voorbeeld